American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis
Authors
Saag, Kenneth G.Teng, Gim Gee
Patkar, Nivedita M.
Anuntiyo, Jeremy
Finney, Catherine
Curtis, Jeffrey R.
Paulus, Harold
Mudano, Amy S.
Pisu, Maria
Elkins-Melton, Mary
Outman, Ryan
Allison, Jeroan J.
Suarez Almazor, Maria
Bridges, S. Louis Jr.
Chatham, W. Winn
Hochberg, Marc
MacLean, Catherine H.
Mikuls, Ted R.
Moreland, Larry W.
O'Dell, James
Turkiewicz, Anthony M.
Furst, Daniel E.
UMass Chan Affiliations
Department of Quantitative Health SciencesDocument Type
Journal ArticlePublication Date
2008-06-03Keywords
Antirheumatic AgentsArthritis, Rheumatoid
Biological Products
*Health Planning Guidelines
Humans
Bioinformatics
Biostatistics
Epidemiology
Health Services Research
Metadata
Show full item recordSource
Arthritis Rheum. 2008 Jun 15;59(6):762-84. Link to article on publisher's siteDOI
10.1002/art.23721Permanent Link to this Item
http://hdl.handle.net/20.500.14038/47698PubMed ID
18512708Related Resources
Link to Article in PubMedae974a485f413a2113503eed53cd6c53
10.1002/art.23721